Ligand Pharmaceuticals Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer John L. Higgins will present at the Oppenheimer 21st Annual Healthcare Conference on Tuesday, November 2, 2010 at 9:40 a.m. Eastern time (6:40 a.m. Pacific). The conference takes place at the Waldorf Astoria in New York.

MORE ON THIS TOPIC